MMJ Recs

MARCH 10, 2024

From eligibility requirements to finding a qualified physician and navigating the application process, we’ll cover everything you need to know to access medical marijuana legally and safely in the state of Texas. Understanding these criteria is vital, as they determine whether individuals can access medical marijuana legally.

Marijuana 52

Marijuana Treatment Epilepsy Access 52

MMJ Recs

OCTOBER 3, 2023

This digital approach streamlines the procedure, making it more accessible to those who may have difficulty attending in-person appointments for various reasons. The online application is available on the official Pennsylvania Department of Health Medical Marijuana Program portal.

History 52

History Conditions Treatment Programs 52

Cannabis Law Report

JUNE 21, 2021

The talks will be made public, open-access on YouTube two weeks after the event. Dr. Stanislav Grof and Brigitte Grof – Stan Grof is the world’s leading researcher in psychedelic therapy, breathwork, and the exploration of non-ordinary states of consciousness, with wife and psychotherapist, Brigitte. Saturday, June 26, 2021.

Events 83

Events History Research and Development Therapy 83

Cannabis Law Report

OCTOBER 12, 2021

Mary Hartnett, Director of Medical Services at Sarah Lawrence College, stated, “safeCircle was our choice given the convenience of its on-site sample collection process, access to high-sensitivity RT-PCR-based testing with rapid turnaround times, ability to scale with our needs, and capacity to ease our administrative burdens.

Programs 52

Programs Clinical Trials Research and Development Therapy 52

Cannabis Law Report

JULY 14, 2022

Register for our new digital learning program. Dear Sean, MAPS is excited to announce the launch of Psychedelic Fundamentals , an online psychedelic education program which provides people with accurate, evidence-based information about psychedelics. Let’s hope they include ethics somewhere on the course. Register Now.

Education 52

Education Research and Development History Programs 52

PrestoDoctor

JANUARY 30, 2024

These include genetics, family history of psychosis, pre-existing mental health conditions, and regular, heavy cannabis use. A family history of psychosis also adds to the risk. Psychotherapy, including cognitive-behavioral therapy, aids individuals in developing coping strategies and addressing underlying psychological issues.

Research and Development 52

Research and Development Treatment Conditions Education 52

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Conducting Psilocybin Integration (14 Hours).

Law 52

Law Programs Therapy Education 52

Canna Care Docs

OCTOBER 2, 2020

Approved patients will have access to over 80 dispensaries throughout the state and may purchase up to a 30 day supply at a time. Each patient will receive one on one assistance navigating the Pennsylvania Medical Marijuana program process and qualified patients will receive a physician’s certification valid for 12 months.

Patients 52

Patients Therapy History Conditions 52

Cannabis Law Report

SEPTEMBER 2, 2021

– Company’s safeCircle™ Testing Program to Monitor for COVID-19 Among On-Campus Unvaccinated Populations –. Under the Contract, ADCL will deploy safeCircle™, its high-throughput, pooled COVID-19 testing program, to provide cost-effective COVID-19 testing. STONY BROOK, N.Y.–(BUSINESS

Clinical Trials 99

Clinical Trials Research and Development Therapy Collective 99

MMJ Recs

DECEMBER 26, 2022

They will review your medical history to ensure you receive a customized, comprehensive, and highly effective pain treatment plan. Advance Spine and Pain Physical Therapy. Another Trenton-based pain clinic, Advance Spine and Pain Physical Therapy has received plenty of praise from past patients. Trenton, NJ. 16096958100.

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

Canna Care Docs

SEPTEMBER 26, 2019

Powered by Sail, we are on a mission to solve the issue of cannabis access for patients. Job Responsibilities: The Medical Practitioner, Medical Doctor (MD), ARPN or Doctor of Osteopathy (DO), will be responsible for: · Perform non-invasive exams and obtain health histories. About Canna Care Docs…. Why Work for CannaCareDocs?

History 40

History DEA Therapy Patients 40

MMJ Recs

OCTOBER 5, 2023

Maryland Medical Cannabis Regulations The Maryland Cannabis Administration (MCA) plays a central role in regulating all aspects of the state’s medical marijuana program. These laws are designed to protect patients, provide access to treatment, and prevent abuse.

Dispensary 52

Dispensary Patients Treatment Conditions 52

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Patients must first schedule an appointment with a licensed medical professional who can evaluate their medical history and condition. In 1996, the state became the first in the U.S.

Dispensary 52

Dispensary Patients Environment Conditions 52

MMJ Recs

SEPTEMBER 19, 2023

These clinics offer a wide range of services to address chronic pain, including advanced procedures and therapies. Patients in Kansas City (as well as the wider Missouri area) have access to top-tier pain management specialists who are dedicated to improving their quality of life. Image by Terry Shultz P.T. on Unsplash 5.

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

Cannabis Law Report

SEPTEMBER 8, 2021

TruTrace Technologies is the developer of fully-integrated software, secured on a blockchain infrastructure, that gives clients’ the ability to store, manage, share and immediately access quality assurance and testing details, COAs, as well as motion and movement intelligence on inventory. For Applied DNA: Investor contact: Sanjay M.

Supply Chain 96

Supply Chain Therapy Pharmaceutical Food 96

Cannabis Law Report

DECEMBER 6, 2021

The Program, an ongoing applied genomics strategy to identify genomic markers that are associated with cotton grown within specific geographies, has identified a biomarker specific to Giza 94, the largest planted Egyptian cotton varietal 1 used in the production of premium cotton textiles. Investor Contact: Sanjay M.

Supply Chain 52

Supply Chain Therapy Research and Development Data 52

Medicinal Marijuana Association

AUGUST 15, 2019

Not only has this form of therapy become a popular agent for physical problems such as chronic pain, insomnia, and fibromyalgia, as well as the side effects from cancer treatments, it has also been effective in treating neurological conditions including Parkinson’s disease and epilepsy. Obtaining a Prescription. Filling Your Prescription.

Therapy 40

Therapy Treatment Chronic Pain Conditions 40

Cannabis Law Report

NOVEMBER 9, 2021

Delic has been focused on opening locations in secondary cities with considerable demand, in an effort to provide access to the most patients. Established history of providing FDA-approved ketamine infusion services: The management team at KWC has been in business for 6 years expanding services throughout the United States.

Treatment 52

Treatment Therapy Media Access 52

Cannabis Law Report

AUGUST 3, 2021

The Contract specifies ADCL’s deployment of safeCircle™, its high-throughput, pooled COVID-19 testing program, to provide weekly asymptomatic diagnostic COVID-19 screening of on-campus unvaccinated students, staff, and faculty, and a random sampling of vaccinated individuals across the CUNY school system.

Clinical Trials 105

Clinical Trials Therapy Collective Research and Development 105

Cannabis Law Report

JULY 9, 2021

The use of psychedelic substances to treat mental illness and physical disorders is known as “psychedelic therapy.” In a typical scenario, psychedelic substances would be used in conjunction with psychotherapy sessions to treat disorders for which other medicinal therapies have failed. Psychedelic therapy is not a fringe phenomenon.

Law 105

Law Therapy Clinical Trials Research and Development 105

Marijuana Packaging

NOVEMBER 23, 2018

Currently, New England Treatment Access (NETA) in Northampton and Cultivate Holdings in Leicester are the two spots that are selling, with the mayor of Northampton being one of the first customers. Mayor David Narkewicz clarified that his purchase was a purely symbolic gesture to honor the historic moment in Massachusetts history.

Legalization 40

Legalization Recreational Therapy Dispensary 40

Canna Care Docs

SEPTEMBER 18, 2020

A medical provider may recommend medical cannabis to treat any condition that they feel may benefit from medical cannabis and cannabinoid-based therapies. Yes, you will be able to upload your records directly to your patient portal which you will receive access to. History of Medical Marijuana in Virginia.

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Cannabis Law Report

JULY 30, 2019

For now, both Florida’s restrictions and federal restrictions on the scheduling of cannabis still apply as states scramble to formulate respective regulations for research, access, education, innovation. In my estimation, the state’s overall program growth in Florida to date is impressive. Pain Foundation.

Marijuana 40

Marijuana Education Patients Research and Development 40

Veriheal

JUNE 29, 2021

Plant medicines and concoctions made from them have been utilized throughout the history of cultures around the world. In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. A Push by Patients.

Therapy 55

Therapy DEA Patients Clinical Trials 55

Cannabis Law Report

DECEMBER 21, 2021

Prakat swiftly modernizes legacy business hardware, software programs, and downloadable apps. In its history, IHG has graduated nearly 8,000 students. Yet, more than half of the people in the least developed countries lack access to electricity. DALRADA SUPPORTS WORLD INITIATIVES.

Research and Development 52

Research and Development Supply Chain Data Business 52

The Cannigma

AUGUST 5, 2022

2 In 2019 the FDA approved a keta m ine-based nasal spray to treat depression that does not respond to other therapies. A 2022 study of 1247 people using at-home ketamine-assisted therapy found that 62% of participants reported a 50%+ improvement in depressive symptoms. But this program offers more than just the ketamine itself.

Treatment 138

Treatment Research and Development Therapy Digestion 138

Cannabis Law Report

JULY 1, 2021

In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency recognized psilocybin as a breakthrough therapy for treatment-resistant depression. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

OCTOBER 24, 2019

We’re witnessing history being made many times over, as the Green Wave of decriminalisation and legalisation of Cannabis rushes across the World. It will allow for regulated, supervised and limited access for our sick citizens especially those with cancer, HIV/ AIDS, glaucoma, and epilepsy.

Law 45

Law Medicine Decriminalization Oil 45

Cannabis Law Report

JANUARY 4, 2022

Hurry, 917-733-5573, sanjay.hurry@adnas.com safeCircle Program Manager: Mike Munzer, 631-240-8814, mike.munzer@adnas.com Web: www.adnas.com Twitter: @APDN. Concurrently, ADCL announced its intention to submit a request for EUA to FDA for the Linea 2.0 The Linea 2.0 Investor Relations Contact: Sanjay M.

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. In MAPS’ 36th year, we’ll learn if our second Phase 3 study of MDMA-assisted therapy for PTSD was successful. At 36, MAPS is now older than I was when I started MAPS at age 32.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

NOVEMBER 5, 2021

Negative testing results yield a ‘green pass’ via CLEARED4 that is texted to the employee’s smartphone that authorizes access to corporate facilities. Vaccinated participants in the safeCircle program are given a ‘blue pass.’ CLEARED4 is helping the world reopen and stay open by issuing 10+ million safe access passes per month.

Compliance 52

Compliance Compliance Research and Development Therapy 52

The Joint Blog

MAY 13, 2020

So we reached out to Eloise Theisen , RN, MSN, AGPCNP-BC, Pacific College of Health and Science faculty ( Medical Cannabis program ), and President of the American Cannabis Nurse Association to get her take on topic. She is a board certified Adult Geriatric Nurse Practitioner who specializes in cannabis therapy. That depends.

Blood Pressure 52

Blood Pressure Tincture Cannabinoids Topical 52

The Cannigma

APRIL 8, 2021

The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. We’ve actually had one or maybe even two cannabis pharmacists on this program before. It’s not a targeted therapy, that’s why it’s so good at symptom relief, but it hasn’t fix much of anything. They’re not taking good med histories.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

SpeedWeed

JULY 19, 2021

In the March 2019 Cannabis Business Times cover story, Dr. Andrea Small-Howard, co-founder and chief science officer of GB Sciences, said, “My personal mission is to take cannabis-based therapies to the U.S. And our program is able to look within all of these plant-based sources for new therapeutic formulations.

Medicine 52

Medicine Research and Development Chronic Pain Programs 52

SpeedWeed

JULY 23, 2021

In the March 2019 Cannabis Business Times cover story, Dr. Andrea Small-Howard, co-founder and chief science officer of GB Sciences, said, “My personal mission is to take cannabis-based therapies to the U.S. And our program is able to look within all of these plant-based sources for new therapeutic formulations.

Research and Development 52

Research and Development Legalization Medicine Chronic Pain 52

SpeedWeed

JULY 22, 2021

In the March 2019 Cannabis Business Times cover story, Dr. Andrea Small-Howard, co-founder and chief science officer of GB Sciences, said, “My personal mission is to take cannabis-based therapies to the U.S. And our program is able to look within all of these plant-based sources for new therapeutic formulations.

Research and Development 52

Research and Development Medicine Chronic Pain Programs 52

The Cannigma

FEBRUARY 16, 2022

Listen & Subscribe: In light of Black History Month, we feel it is important and relevant to talk about how minorities in the United States and around the world have been disproportionately affected by drug policy and the war on drugs. EG: So, it is February, which means it’s Black History Month in the US right, Codi?

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73